PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 18, 2022SHILAP Revista de lepidopterología46 citationsOpen Access

Phylogeny, Antifungal Susceptibility, and Point Mutations of SQLE Gene in Major Pathogenic Dermatophytes Isolated From Clinical Dermatophytosis

View Full Paper
NPNasrin PashootanMSMasoomeh Shams‐GhahfarokhiANArash Chaichi Nusrati

Key Points

Key points are not available for this paper at this time.

Abstract

Drug resistance is one of the major challenges to skin fungal infections, especially in tropical and subtropical infections caused by dermatophytes. This study aimed to determine the antifungal susceptibility of clinically dermatophytes and evaluate point mutations in terbinafine-resistant isolates. A total number of 123 clinical dermatophyte isolates in eight species were evaluated in terms of sensitivity to seven major antifungals. Furthermore, the point mutation in squalene epoxidase (SQLE) gene responsible for terbinafine resistance was studied. The dermatophytes species were identified by morphological characteristics and confirmed by the ITS sequencing. Also, the phylogenetic tree was drawn using the RAxML analyses for 123 dermatophytes isolates. A new XXIX genotype was also found in 4 Trichophyton mentagrophytes isolates. Based on the results obtained, terbinafine was the most effective antifungal drug followed by itraconazole and voriconazole. Trichophyton rubrum and Trichophyton tonsurans were the most susceptible species (MIC50 = 0.01, 0.09 μg/ml), and T. mentagrophytes was the most resistant species (MIC50 = 0.125 μg/ml) to terbinafine. Of the 123 dermatophytes isolates, six isolates showed reduced susceptibility to terbinafine, and only Trichophyton indotineae had a mutation in SQLE gene as a Phe397Leu substitution. Overall, the antifungal susceptibility test is necessary for managing dermatophytosis. These results help physicians to control the course of the disease and provide further insights to select effective drugs for patients with dermatophytosis, especially in tropical and subtropical regions of the world, where dermatophytosis is still a public health problem.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pashootan et al. (2022) studied this question.

synapsesocial.com/papers/69dd4af57d97b7e86940ca11https://doi.org/10.3389/fcimb.2022.851769
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of genes involved in terbinafine resistance in Aspergillus nidulans2002 · 15 citations
  2. 2RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies2014 · 34,798 citations
  3. 3Basidiomycetous Yeasts from Boletales Fruiting Bodies and Their Interactions with the Mycoparasite Sepedonium chrysospermum and the Host Fungus Paxillus2011 · 42 citations
  4. 4Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine2002 · 292 citations
  5. 5Multidrug‐resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature2020 · 90 citations